` FDBK (Feedback PLC) vs FTSE All Share Index Comparison - Alpha Spread

FDBK
vs
F
FTSE All Share Index

Over the past 12 months, FDBK has outperformed FTSE All Share Index, delivering a return of -58% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
FDBK vs FTSE All Share Index

Loading
FDBK
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
FDBK vs FTSE All Share Index

Loading
FDBK
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
FDBK vs FTSE All Share Index

Loading
FDBK
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Feedback PLC vs Peers

FTSE All Share Index
FDBK
VEEV
PME
2413
DOCS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Feedback PLC
Glance View

Market Cap
3.4m GBX
Industry
Health Care

Feedback Plc operates as an investing company, which seeks to acquire a direct interest in one or more companies in the technology sector. The principal activity of the Company is the development and commercialization of its technologies, including Bleepa, the image-based communication platform for frontline clinicians; CareLocker, the patientcentric cloud architecture, and Bleepa Box, store and forward technology. The company offers TexRAD, which provides radiologists, clinicians and medical researchers with a non-invasive imaging biomarker. Its TexRAD’s algorithm extracts and quantifies texture features in pre-existing medical images. These texture features are used to demonstrate diagnostic, prognostic and predictive intelligence in scientific research with particular focus in oncology. The company offers Cadran, a suite of picture archiving storage, management and display system for medical images. The company also provides consultancy services for medical image management within organizations. The company offers TexRAD Lung, a software tool for the analysis of lung cancer.

FDBK Intrinsic Value
7.05 GBX
Overvaluation 10%
Intrinsic Value
Price
Back to Top